Viewing nowBialsartan Tablet 100 mg (Losartan Potassium)
Losartan Potassium 100mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

MFDS item code 200708590 · Notified 2007.07.25
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used in the treatment of patients with hypertension and kidney disease due to hypertension in patients with type 2 diabetes.
(Tablets) This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be given orally in 2 divided doses per day or, if necessary, increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years or younger. For elderly patients over 75 years, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular effective circulating volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretic treatment) (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Children and adolescents 6 years of age and older (1) Patients weighing 20 kg or more and less than 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication may cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, if pregnancy is confirmed, it should be discontinued immediately. During pregnancy, a decrease in amniotic fluid can inhibit fetal lung development and cause skeletal deformities, and risks of oliguria, hypotension, and renal failure may occur in newborns. Patients who are allergic to this medication, pregnant or potentially pregnant women, patients with severe liver impairment, and patients with certain genetic diseases should not take it. Additionally, patients with moderate to severe kidney impairment among diabetics should avoid combining this medication with specific drugs. Elderly patients, those with hyperkalemia, mild to moderate liver impairment, and patients with valvular heart disease should take this medication with caution, as blood pressure may drop suddenly, requiring careful monitoring. Side effects during treatment may include muscle cramps, back pain, dizziness, upper respiratory infections, and, rarely, serious adverse reactions such as angioedema, hepatitis, and muscle damage. Particularly, patients at risk of hyperkalemia may require regular blood tests due to potential elevations in serum potassium levels. This medication may affect liver and kidney function, so dose adjustments and caution are necessary in patients with liver or kidney diseases. If symptoms of dizziness or fainting occur due to excessively low blood pressure, immediate consultation with a healthcare provider is necessary. Furthermore, this medication may interact with specific drugs, so patients should inform their healthcare provider about any other medications they are taking. Women who are pregnant or breastfeeding should avoid taking this medication, and if it is unavoidable, breastfeeding should be discontinued. The safety and efficacy of this medication have not been sufficiently established in children under 6 years of age or in pediatric patients with severely impaired renal function, and therefore, it is not administered. In cases of overdose, hypotension and heart rate changes may occur, requiring prompt emergency treatment. Patients taking this medication should consult their healthcare provider regarding pregnancy plans or potassium supplement usage, and the medication should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture and should be kept at room temperature between 1°C and 30°C. This storage will help maintain the medication's efficacy for a longer period.
White drop-shaped film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 100mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.